[1] Gottlieb MS, Schanker HM, Fan PT, Saxon A, Weisman JD, Pozalski I. Pneumocystis pneumonia--Los Angeles. MMWR Morb Mortal Wkly Rep 1981;30(21):250-2. https://pubmed.ncbi.nlm.nih.gov/6265753/.https://pubmed.ncbi.nlm.nih.gov/6265753/
[2] Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220(4599):868 − 71. http://dx.doi.org/10.1126/science.6189183CrossRef
[3] Nahmias AJ, Weiss J, Yao X, Lee F, Kodsi R, Schanfield M, et al. Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959. Lancet 1986;327(8492):1279 − 80. http://dx.doi.org/10.1016/S0140-6736(86)91422-4CrossRef
[4] Motulsky AG, Vandepitte J, Fraser GR. Population genetic studies in the Congo. I. Glucose-6-phosphate dehydrogenase deficiency, hemoglobin S, and malaria. Am J Hum Genet 1966;18(6):514-37. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1706206/.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1706206/
[5] Zhu TF, Korber BT, Nahmias AJ, Hooper E, Sharp PM, Ho DD. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 1998;391(6667):594 − 7. http://dx.doi.org/10.1038/35400CrossRef
[6] Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, Bunce M, et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008;455(7213):661 − 4. http://dx.doi.org/10.1038/nature07390CrossRef
[7] Woo PCY, Lau SKP, Chu CM, Chan KH, Tsoi HW, Huang Y, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 2005;79(2):884 − 95. http://dx.doi.org/10.1128/JVI.79.2.884-895.2005CrossRef
[8] Sloots TP, McErlean P, Speicher DJ, Arden KE, Nissen MD, Mackay IM. Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J Clin Virol 2006;35(1):99 − 102. http://dx.doi.org/10.1016/j.jcv.2005.09.008CrossRef
[9] Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Coronavirus HKU1 infection in the United States. Emerg Infect Dis 2006;12(5):775 − 9. http://dx.doi.org/10.3201/eid1205.051316CrossRef
[10] Ruohola A, Waris M, Allander T, Ziegler T, Heikkinen T, Ruuskanen O. Viral etiology of common cold in children, Finland. Emerg Infect Dis 2009;15(2):344 − 6. http://dx.doi.org/10.3201/eid1502.081468CrossRef
[11] Góes LG, Durigon EL, Campos AA, Hein N, Passos SD, Jerez JA. Coronavirus HKU1 in children, Brazil, 1995. Emerg Infect Dis 2011;17(6):1147 − 8. http://dx.doi.org/10.3201/eid1706.101381CrossRef
[12] Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med 2011;364(16):1523 − 32. http://dx.doi.org/10.1056/NEJMoa1010095CrossRef
[13] Bao CJ, Guo XL, Qi X, Hu JL, Zhou MH, Varma JK, et al. A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis 2011;53(12):1208 − 14. http://dx.doi.org/10.1093/cid/cir732CrossRef
[14] Liu Y, Li Q, Hu WF, Wu JB, Wang YB, Mei L, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector Borne Zoonotic Dis 2012;12(2):156 − 60. http://dx.doi.org/10.1089/vbz.2011.0758CrossRef
[15] Hu JL, Shi C, Li ZF, Guo XL, Qian YH, Tan WW, et al. A cluster of cases of severe fever with thrombocytopenia syndrome bunyavirus infection in China, 1996: a retrospective serological study. PLoS Negl Trop Dis 2018;12(6):e0006603. http://dx.doi.org/10.1371/journal.pntd.0006603CrossRef
[16] Li AQ, Liu L, Wu W, Liu Y, Huang XX, Li C, et al. Molecular evolution and genetic diversity analysis of SFTS virus based on next-generation sequencing. Biosaf Health 2021;3(2):105 − 115. http://dx.doi.org/10.1016/j.bsheal.2021.02.002CrossRef
[17] Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367(19):1814 − 20. http://dx.doi.org/10.1056/NEJMoa1211721CrossRef
[18] Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 2014;370(26):2499 − 505. http://dx.doi.org/10.1056/NEJMoa1401505CrossRef
[19] Memish ZA, Mishra N, Olival KJ, Fagbo SF, Kapoor V, Epstein JH, et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 2013;19(11):1819 − 23. http://dx.doi.org/10.3201/eid1911.131172CrossRef
[20] Meyer B, Müller MA, Corman VM, Reusken CBEM, Ritz D, Godeke GJ, et al. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis 2014;20(4):552 − 9. http://dx.doi.org/10.3201/eid2004.131746CrossRef
[21] Alagaili AN, Briese T, Mishra N, Kapoor V, Sameroff SC, De Wit E, et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. mBio 2014;5(2):e00884 − 14. http://dx.doi.org/10.1128/mBio.00884-14CrossRef
[22] Müller MA, Corman VM, Jores J, Meyer B, Younan M, Liljander AM, et al. MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg Infect Dis 2014;20(12):2093 − 5. http://dx.doi.org/10.3201/eid2012.141026CrossRef
[23] Apolone G, Montomoli E, Manenti A, Boeri M, Sabia F, Hyseni I, et al. Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy. Tumori 2021;107(5):446 − 51. http://dx.doi.org/10.1177/0300891620974755CrossRef
[24] Amendola A, Bianchi S, Gori M, Colzani D, Canuti M, Borghi E, et al. Evidence of SARS-CoV-2 RNA in an oropharyngeal swab specimen, Milan, Italy, early December 2019. Emerg Infect Dis 2021;27(2):648 − 50. http://dx.doi.org/10.3201/eid2702.204632CrossRef
[25] Gianotti R, Barberis M, Fellegara G, Galván-Casas C, Gianotti E. COVID-19-related dermatosis in November 2019: could this case be Italy's patient zero? Br J Dermatol 2021;184(5):970-1. http://dx.doi.org/10.1111/bjd.19804.http://dx.doi.org/10.1111/bjd.19804
[26] Amendola A, Canuti M, Bianchi S, Kumar S, Fappani C, Gori M, et al. Molecular evidence for SARS-CoV-2 in samples collected from patients with morbilliform eruptions since late 2019 in Lombardy, Northern Italy. Lancet 2022;215:113979. http://dx.doi.org/10.1016/j.envres.2022.113979CrossRef
[27] https://www.northjersey.com/story/news/essex/belleville/2020/04/30/belleville-nj-mayor-tests-positive-coronavirus-antibodies/3057925001/. [2020-4-30].https://www.northjersey.com/story/news/essex/belleville/2020/04/30/belleville-nj-mayor-tests-positive-coronavirus-antibodies/3057925001/
[28] Basavaraju SV, Patton ME, Grimm K, Rasheed MAU, Lester S, Mills L, et al. Serologic testing of US blood donations to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-reactive antibodies: December 2019-January 2020. Clin Infect Dis 2021;72(12):e1004 − 9. http://dx.doi.org/10.1093/cid/ciaa1785CrossRef
[29] https://www.nih.gov/news-events/news-releases/nih-study-offers-new-evidence-early-sars-cov-2-infections-us. [2021-6-15].https://www.nih.gov/news-events/news-releases/nih-study-offers-new-evidence-early-sars-cov-2-infections-us
[30] https://abcnews.go.com/Health/wireStory/evidence-suggests-covid-19-us-christmas-2019-78288906. [2021-6-16].https://abcnews.go.com/Health/wireStory/evidence-suggests-covid-19-us-christmas-2019-78288906
[31] Althoff KN, Schlueter DJ, Anton-Culver H, Cherry J, Denny JC, Thomsen I, et al. Antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in all of us research program participants, 2 January to 18 March 2020. Clin Infect Dis 2022;74(4):584 − 90. http://dx.doi.org/10.1093/CID/CIAB519CrossRef
[32] Deslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar JR, et al. SARS-CoV-2 was already spreading in France in late December 2019. Int J Antimicrob Agents 2020;55(6):106006. http://dx.doi.org/10.1016/j.ijantimicag.2020.106006CrossRef
[33] La Rosa G, Mancini P, Bonanno Ferraro G, Veneri C, Iaconelli M, Bonadonna L, et al. SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring. Sci Total Environ 2021;750:141711. http://dx.doi.org/10.1016/j.scitotenv.2020.141711CrossRef
[34] Fongaro G, Stoco PH, Souza DSM, Grisard EC, Magri ME, Rogovski P, et al. The presence of SARS-CoV-2 RNA in human sewage in Santa Catarina, Brazil, November 2019. Sci Total Environ 2021;778:146198. http://dx.doi.org/10.1016/j.scitotenv.2021.146198CrossRef
[35] Chavarria-Miró G, Anfruns-Estrada E, Guix S, Paraira M, Galofré B, Sánchez G, et al. Sentinel surveillance of SARS-CoV-2 in wastewater anticipates the occurrence of COVID-19 cases. medRxiv 2020. http://dx.doi.org/10.1101/2020.06.13.20129627.http://dx.doi.org/10.1101/2020.06.13.20129627
[36] Wang QH, Chen H, Shi Y, Hughes AC, Liu WJ, Jiang JK, et al. Tracing the origins of SARS-CoV-2: lessons learned from the past. Cell Res 2021;31(11):1139 − 41. http://dx.doi.org/10.1038/S41422-021-00575-WCrossRef